Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata
(Adnkronos) – LONDON, Nov. 1, 2023 /PRNewswire/ — Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild
